ViiV’s HIV regimen hit with setback in the US

23rd December 2019 Uncategorised 0

US regulators have declined ViiV Healthcare’s application to market an investigational long-acting regimen for the treatment of HIV

More: ViiV’s HIV regimen hit with setback in the US
Source: News